ConductScience.org, home

Gene · 1066

Papers3,256

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

221 to 240 of 3,256

Download this page as JSON
TitleJournalYearPMIDFound bySource
Emerging Lipid Targets in Glioblastoma.Cancers (Basel)202438254886PubTator, text miningPubMed
Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults.Sci Rep202438253816PubTator, text miningPubMed
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances Potency.J Pharmacol Exp Ther202438253384PubTator, text miningPubMed
Super enhancer loci of EGFR regulate EGFR variant 8 through enhancer RNA and strongly associate with survival in HNSCCs.Mol Genet Genomics202438236481PubTator, text miningPubMed
Discovery of a novel marine Bacteroidetes with a rich repertoire of carbohydrate-active enzymes.Comput Struct Biotechnol J202438235362PubTator, text miningPubMed
Predictive factors for the development of capecitabine-induced hand-foot syndrome: a retrospective observational cohort study.Ann Med Surg (Lond)202438222767PubTator, text miningPubMed
ACAT2 may be a novel predictive biomarker and therapeutic target in lung adenocarcinoma.Cancer Rep (Hoboken)202438213102PubTator, text miningPubMed
Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.Chest202438211700PubTator, text miningPubMed
Oxophilic Ce single atoms-triggered active sites reverse for superior alkaline hydrogen evolution.Nat Commun202438200045PubTator, text miningPubMed
Acyl-coenzyme A: cholesterol acyltransferase inhibitor avasimibe suppresses tumorigenesis and induces G1-phase cell-cycle arrest by activating PPARγ signaling pathway in bladder cancer.J Cancer202438169575PubTator, text miningPubMed
Identification of novel biomarkers based on lipid metabolism-related molecular subtypes for moderately severe and severe acute pancreatitis.Lipids Health Dis202438169383PubTator, text miningPubMed
Synthesis and evaluation of indomethacin prodrugs with a diester structure that are metabolically activated by human carboxylesterases.Xenobiotica202438142303PubTator, text miningPubMed
Developing an adult stem cell derived microphysiological intestinal system for predicting oral prodrug bioconversion and permeability in humans.Lab Chip202438099395PubTator, text miningPubMed
Functional roles and localization of hydrolases in the Japanese mitten crab Eriocheir japonica.Comp Biochem Physiol B Biochem Mol Biol202438097062PubTator, text miningPubMed
Identification of the first selective bioluminescent probe for real-time monitoring of carboxylesterase 2 in vitro and in vivo.Analyst202438078792PubTator, text miningPubMed
Inhibitory effects of phthalate esters (PAEs) and phthalate monoesters towards human carboxylesterases (CESs).Toxicol Appl Pharmacol202438070751PubTator, text miningPubMed
Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies.Br J Clin Pharmacol202438048692PubTator, text miningPubMed
JANUS, a spliceosome-associated protein, promotes miRNA biogenesis in Arabidopsis.Nucleic Acids Res202437994727PubTator, text miningPubMed
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.J Clin Psychopharmacol202437851403PubTator, text miningPubMed
Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study.CPT Pharmacometrics Syst Pharmacol202437775990PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1066/papers?page=12